SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending due to a surge in social dominance and trading volume, driven by renewed interest in its quantum-resistant technology and strategic positioning in the US market. The community is actively discussing the coin's perceived undervaluation, potential for a long-term breakout, and recent network activity, with many retail investors debating the timing of a reversal from recent lows.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is currently seeing heavy trading volume and heightened investor interest following a partnership announcement with NVIDIA, which includes a multi-billion dollar strategic investment aimed at scaling AI infrastructure. While bullish participants point to the company's central role in the AI supply chain and potential for sustained revenue growth, others are closely watching key technical resistance levels around the $100 mark and navigating significant volatility driven by options flow and broader market uncertainty.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is generating intense community engagement as holders focus on its identity as a permissionless brand that incentivizes real-world product development and grassroots marketing. Supporters are actively showcasing their conviction by organizing in-person events and launching diverse initiatives, positioning the project as a long-term, community-driven play.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as investors react to strong quarterly earnings, where the company reported significant year-over-year revenue growth and increased its 2026 revenue guidance. The community is actively discussing the company's expanding customer base and potential for long-term growth as a key battery supplier within the drone and defense sectors, while also debating the stock's volatility and the impact of upcoming warrant triggers.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as the community speculates on a potential buyout, particularly by Incyte, driven by the strong commercial trajectory of its FDA-approved drugs Revuforj and Niktimvo. Investors are closely watching for clinical data updates at the upcoming ASH meeting, with many debating the competitive landscape versus Kura Oncology while viewing the stock as significantly undervalued relative to its oncology peers.

Abacus Global Management, Inc. is a pioneering alternative asset manager specializing in uncorrelated financial products that leverage proprietary longevity data and actuarial technology. It operates through the following business segments: Asset Management, Life Solutions and Technology Services. The Asset Management segment provides asset management services primarily to institutional investors, as well as private clients, investing in uncorrelated longevity-based assets, fixed-income replacement strategies, and free cash flow–based investment solutions. The Life Solutions segment is engaged in the buying, selling, and trading of policies, as well as maintaining policies until the receipt of death benefits. The Technology Services segment provides real-time mortality verification, missing participant verification, and other life insurance–specific services to customers on a contract basis. The company was founded by Matthew Ganovsky, Kevin Scott Kirby, and Todd Sean McNealy in 2004 and is headquartered in Orlando, FL.

Abacus Global Management Inc. - Ordinary Shares - Class A

Abacus Global Management is capturing investor attention as its vertical integration strategy, highlighted by a major strategic stake in Manning & Napier, signals a push to control both the origination and distribution of wealth and insurance solutions. While the stock has seen significant momentum, community discussion is currently polarized between those bullish on the company's record growth and platform scalability and those concerned by recent price volatility and technical trading pressures.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

Lightpath Technologies is trending as investors monitor ongoing institutional supply absorption and potential contract catalysts, particularly related to the Next-Generation Short-Range Interceptor program. The community is actively debating the impact of recent selling by North Run Strategies while maintaining bullish conviction on the company's long-term positioning as a domestic supplier of critical infrared optics for defense and aerospace.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following a massive surge in March delivery numbers that significantly beat growth expectations, fueling strong community excitement for potential profitability. Investors are actively discussing the company's multi-brand expansion and the potential for a short squeeze as the stock continues to test key resistance levels.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is currently trending as investors weigh significant revenue growth guidance and the securing of strategic defense contracts for missile propulsion and autonomous swarm technology. While long-term supporters point to the firm's role in critical defense infrastructure, the community remains divided, with active discussions focused on the potential for a short squeeze driven by heavy short interest and the stock's recent high-volume volatility.

Dave, Inc. is a digital banking service. Its products include a budgeting tool to help members manage their upcoming bills to avoid overspending, cash advances through its flagship ExtraCash product to help members avoid punitive overdraft fees, a Side Hustle product, where Dave helps connect members with supplemental work opportunities, and Dave Banking, a modern checking account experience with valuable tools for building long-term financial health. The company was founded by Jason Wilk, Paras Chitrakar, and John Wolanin in October 2015 and is headquartered in Los Angeles, CA.

Dave Inc - Ordinary Shares - Class A

Dave Inc. is trending as investors weigh strong operational performance and share buyback initiatives against technical volatility and concerns regarding potential regulatory oversight. The community remains divided, with many highlighting the stock's operating leverage and growth potential, while others express caution due to ongoing legal developments and broader sector-wide sensitivity to credit regulations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prestige Consumer Healthcare Becomes Oversold (PBH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month Low - Here's Why

Prestige Consumer Healthcare (NYSE:PBH) Reaches New 12-Month Low - Here's Why...

Allspring Global Investments Holdings LLC Acquires 21,085 Shares of Prestige Consumer Healthcare Inc. $PBH

Allspring Global Investments Holdings LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.3% during the fourth quarter, according to the company in...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Recommendation of "Hold" from Brokerages

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has been assigned an average recommendation of "Hold" from the seven research firms that are covering the firm, Marketbeat reports. Four...

Congress Asset Management Co. Has $20.91 Million Stock Position in Prestige Consumer Healthcare Inc. $PBH

Congress Asset Management Co. increased its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 14.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 339,018 shares of the company's stock after acquiring an...

Prestige Consumer Healthcare Inc. $PBH Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 30.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 459,228 shares of the company's stock after buying an additiona...

Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up   - Time to Buy?

Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up - Should You Buy...

Prestige Bets $1 Billion On World's Most Iconic Nasal Strip

Prestige Consumer Healthcare acquires Breathe Right brand for $1.045 billion. Deal expands OTC portfolio into sleep & breathing categories.read more...

Prestige Consumer Healthcare Inc. (NYSE:PBH) Short Interest Up 18.0% in February

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) saw a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling...

Prestige Consumer Healthcare Inc. $PBH Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 24.8% in the 3rd quarter, according to the company in its most recent Form 13F...

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Prestige Consumer Healthcare Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

PBH
Prestige Consumer Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PBH News

PBHPrestige Consumer Healthcare Inc